Status:
COMPLETED
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Diabetes
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
The hyperglycemic response to surgery and the added effect of low-dose steroids (dexamethasone 4 to 8mg), and whether these differ in diabetics and nondiabetics remain unclear. Therefore, we prospecti...
Eligibility Criteria
Inclusion
- elective surgery under anesthesia
Exclusion
- \< 50 kg
- emergency
- insulin therapy
- cardiac surgery
- refusal
- hyperglycemia\> 2g/L
Key Trial Info
Start Date :
September 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03390179
Start Date
September 4 2017
End Date
February 28 2018
Last Update
July 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cuvillon
Nîmes, Gard, France, 30000